BLOG
Promoting the healthy development of the medical testing and diagnostic industry
Innovation-driven, dual high-end development of products and production lines | The 20th National Congress of the Communist Party of China
On the afternoon of the 18th, reporters visited Aiwei Technology Park located in Yuelu High-tech Zone. A strong atmosphere of learning was palpable; the hall's electronic screen displayed slogans such as "Celebrating the Successful Opening of the 20th National Congress of the Communist Party of China" and "Implementing the Spirit of the 20th National Congress of the Communist Party of China." "The timely study and understanding of the spirit of the 20th National Congress of the Communist Party of China allows the company to find the right direction for development." said Lin Changqing, the company's vice general manager.

Aiwei Technology's main business includes the research, development, production, sales, and after-sales service of medical testing and analysis instruments, in vitro diagnostic reagents, and medical consumables. Its business covers more than 40 countries and regions worldwide.
"In the 22 years since its establishment, we have focused on one thing: achieving automation in medical microscopic examinations, making medical microscopy more convenient and intelligent." Lin Changqing told reporters that Aiwei Technology's main business includes the research, development, production, sales, and after-sales service of medical testing and analysis instruments, in vitro diagnostic reagents, and medical consumables, covering more than 40 countries and regions worldwide.
In the past, medical testing of urine, stool, blood, and other specimens had a low degree of automation, relying heavily on manual operations, requiring multiple steps such as manual sampling, reagent addition, microscopic observation, manual recording, and conclusion drawing. Aiwei Technology took the lead in applying artificial intelligence and machine vision technology to the morphological examination of clinical pathological specimens, filling a technological gap in the international field of automated morphological examination by medical microscopes and changing the history of clinical medical microscopic examination primarily relying on manual microscopy.
"Now, you only need to place the sample in the designated location; the machine will handle the rest of the work until an objective and detailed test report is produced." Lin Changqing said that the intelligent development of microscopy has effectively improved the accuracy and speed of clinical testing of related specimens, reduced the workload of testers, eliminated cross-contamination, and provided patients with a more accurate, intelligent, and efficient testing method.
The report of the 20th National Congress of the Communist Party of China proposed the construction of a modernized industrial system, insisting on focusing economic development on the real economy and promoting new industrialization. In Lin Changqing's view, an important mark of a modernized industrial system lies in the production process and products keeping pace with the times, using information technology, big data, and artificial intelligence to move towards high-end intelligent manufacturing.
Entering Aiwei Technology's consumable production workshop, automated production lines are neatly arranged. A robotic arm continuously "picks up" four 3cm long and 1cm wide transparent glass slides, precisely placing them in the slots of a black tray. After several repetitions, a box of counting plates can proceed to the next production stage.
"Except for the final packaging stage, which requires some manual labor, other production processes can be automated." A workshop official told reporters that as a pilot enterprise for intelligent manufacturing in Changsha, Aiwei Technology's consumable workshop only needs dozens of people to meet the annual production task of over 100 million yuan.
The report of the 20th National Congress of the Communist Party of China points out that we must adhere to the principle that technology is the primary productive force, talent is the primary resource, and innovation is the primary driving force. It is understood that innovation-driven development is the key to Aiwei Technology's rapid growth. Currently, the company has applied for more than 300 patents and has been granted more than 200 valid patents.
In 2016, Aiwei's production line entered the Yuelu High-tech Zone. On June 16, 2021, Aiwei Technology was listed on the Science and Technology Innovation Board. "Such rapid development is inseparable from the strong support of the Xiangjiang New Area and Yuelu High-tech Zone Management Committee." Lin Changqing told reporters that from the initial element guarantee and talent recruitment to safety production, financial subsidies, and listing guidance, the Xiangjiang New Area and Yuelu High-tech Zone Management Committee have always provided the enterprise with warm-hearted services to help it grow. The park and the enterprise have truly achieved what General Secretary Xi Jinping emphasized when participating in the discussion of the Guangxi delegation at the 20th National Congress of the Communist Party of China: "thinking together and working together."
Latest News